# BETAMETHASONE DIPROPIONATE
> **ANDA211722** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2020-06-17
## Drug
- **FDA Application Number:** ANDA211722
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BETAMETHASONE DIPROPIONATE
- **Generic name:** BETAMETHASONE DIPROPIONATE
- **Active ingredients:** BETAMETHASONE DIPROPIONATE
- **Dosage form:** SPRAY
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** SUN PHARMA CANADA
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2020-06-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211722)
---
*AI Analytics · CC0 1.0*